Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
AOD-9604 is not a substitute for GLP-1 agonists in clinical obesity
Additionally, as prescription-only injectable medications, carrying documentation when travelling with GLP-1 treatments is strongly recommended
Treating a patient population already diagnosed with a neurodevelopmental or neurodegenerative disorder presents greater challenges than what is presented in a laboratory, since these patients will present with varying levels of disease severity and/or progression with associated cellular damage and neuroinflammation
However, the use of GLP-1 medications for weight management does not align with these trends
US$ 28.47
US$ 23.22
US$ 25.44
US$ 24.76
US$ 21.96
US$ 20.15
US$ 28.84
